Trials / Completed
CompletedNCT00764140
Tumor Growth Factors in Hepatocellular Carcinoma
Insulin-like Growth Factors (IGF) Axis (IGFs, Its Binding Proteins,Receptors), Transforming Growth Factor Alpha and Beta 1 and Epidermal Growth Factor in the Urine and Serum of Patients With Hepatocellular Carcinoma.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Malignant cells frequently produce many tumor growth factors to autocidal or endocrinal proliferate growth, metastasis,or angiogenesis about tumor cells. By studying tumor growth factors in hepatocellular carcinoma, one may know the tumor behavior, its relationship with clinical manifestation or invasion, and could be used as diagnostic or prognostic tools.This study aims to study the relationship between tumor growth factors in HCC ant its clinical relevance.
Detailed description
The clinical relevance of patients will be evaluated by the concentrations of tumor growth factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | tumor growth factor concentration | spot urine or blood collection will be used to measure specific tumor growth factor |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2008-10-01
- Last updated
- 2013-04-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00764140. Inclusion in this directory is not an endorsement.